Robin Hyde-Deruyscher Email & Phone Number

Durham, North Carolina, US

Cambridge, MA, US

• Led initiatives to build systems to capture data to control raw material variability: Developed a system for monitoring raw materials used in manufacturing.
• Worked with senior leaders from all manufacturing sites to define requirements.
• Performed gap analysis studies and presented proposals to senior leadership for agreement.
• Implement plans in multiple global departments to collect data and used to reduce failure rates and variability. Preapproval Inspections for all new Biogen Products globally: Direct responsibility as the global.
• Spent many hours with and in inspection rooms at all sites answering questions about each process and the global approach from Biogen to manufacturing.
• All of these molecules are now approved.

Cambridge, MA, US

Managed the Cell Culture group. Supervised 10-15 associates responsible for technical support of manufacturing, focusing on stages in which cells were grown to produce product. Served as the Technical expert for all aspects of this area not only on site, but also to a large extent globally as a new facility was being built in Denmark and the support group.

Cambridge, MA, US

Cell Biologist in lab based group with responsibility to understand and reduce variability in cell culture metabolism during large scale manufacturing. These shifts in metabolism had deleterious impacts on yield and product quality and were a major concern as they impacted success rates and cost of goods.

• Discovery Research to discover peptides suitable for adhering therapeutic proteins to surgical implants.
• Discovered several peptide families that bound with high affinity to titanium.
• Discovered peptides that bound with high affinity to bone morphogenetic protein-2 (BMP-2).
• Carried out proof of concept studies proving that BMP-2 could be bound to titanium using a bifunctional peptide composed of the elements described above.
• Multiple issued patents from this work.

Technology Development and drug discovery using combinatorial peptides to build high-throughput screens to discover small molecules that target proteins of unknown function.First scientist hired at Novalon. Used Phage Display technology to create combinatorial peptide libraries containing over a trillion peptides. Information gleaned in the first year of.

Princeton, NJ, US

Focus on Transcriptional Repressor YY1 to understand DNA binding and produce KO mice using embryonic stem cells

Phd, Molecular Biology And Biochemistry

Bs, Biology, Music